Advertisement
Screener

G1 THERAPEUTICS, INC. Operating Cash Flow

G1 THERAPEUTICS, INC. Operating Cash Flow

G1 THERAPEUTICS, INC. reported Operating Cash Flow of -$14.17 million for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2024-08-08

  • G1 THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2024-06-30 was -$5.27M, a 137.44% decline year-over-year.
  • G1 THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2024-03-31 was -$8.90M.
  • G1 THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2023-12-31 was -$12.79M.
  • G1 THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2023-09-30 was -$10.58M.
  • G1 THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$38.34M.
  • G1 THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$128.62M.
  • G1 THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2021 was -$132.11M.
  • G1 THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2020 was -$83.74M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 month
2024-06-30-$5.27M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$14.17M
10-Q · filed 2024-08-08
-$26.96M
derived: sum of 3 quarters · filed 2024-08-08
-$37.54M
derived: sum of 4 quarters · filed 2024-08-08
2024-03-31-$8.90M
10-Q · filed 2024-05-01
-$21.69M
derived: sum of 2 quarters · filed 2024-05-01
-$32.27M
derived: sum of 3 quarters · filed 2024-05-01
-$18.18M
derived: sum of 4 quarters · filed 2024-08-08
2023-12-31-$12.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
-$23.37M
derived: sum of 2 quarters · filed 2024-02-28
-$9.28M
derived: sum of 3 quarters · filed 2024-08-08
-$38.34M
10-K · filed 2024-02-28
2023-09-30-$10.58M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
$3.51M
derived: sum of 2 quarters · filed 2024-08-08
-$25.55M
10-Q · filed 2023-11-01
-$56.18M
derived: sum of 4 quarters · filed 2024-08-08
2023-06-30$14.09M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$14.97M
10-Q · filed 2024-08-08
-$45.60M
derived: sum of 3 quarters · filed 2024-08-08
-$66.85M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$29.05M
10-Q · filed 2024-05-01
-$59.69M
derived: sum of 2 quarters · filed 2024-05-01
-$80.93M
derived: sum of 3 quarters · filed 2024-05-01
-$119.49M
derived: sum of 4 quarters · filed 2024-05-01
2022-12-31-$30.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
-$51.88M
derived: sum of 2 quarters · filed 2024-02-28
-$90.44M
derived: sum of 3 quarters · filed 2024-02-28
-$128.62M
10-K · filed 2024-02-28
2022-09-30-$21.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
-$59.80M
derived: sum of 2 quarters · filed 2023-11-01
-$97.99M
10-Q · filed 2023-11-01
-$132.65M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30-$38.56M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02
-$76.74M
10-Q · filed 2023-08-02
-$111.40M
derived: sum of 3 quarters · filed 2024-02-28
-$145.48M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31-$38.18M
10-Q · filed 2023-05-03
-$72.84M
derived: sum of 2 quarters · filed 2024-02-28
-$106.92M
derived: sum of 3 quarters · filed 2024-02-28
-$143.41M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31-$34.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
-$68.74M
derived: sum of 2 quarters · filed 2024-02-28
-$105.23M
derived: sum of 3 quarters · filed 2024-02-28
-$132.11M
10-K · filed 2024-02-28
2021-09-30-$34.08M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02
-$70.57M
derived: sum of 2 quarters · filed 2022-11-02
-$97.45M
10-Q · filed 2022-11-02
-$128.96M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30-$36.49M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03
-$63.37M
10-Q · filed 2022-08-03
-$94.88M
derived: sum of 3 quarters · filed 2023-03-01
-$91.24M
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31-$26.88M
10-Q · filed 2022-05-04
-$58.39M
derived: sum of 2 quarters · filed 2023-03-01
-$54.75M
derived: sum of 3 quarters · filed 2023-03-01
-$83.60M
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31-$31.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
-$27.87M
derived: sum of 2 quarters · filed 2023-03-01
-$56.72M
derived: sum of 3 quarters · filed 2023-03-01
-$83.74M
10-K · filed 2023-03-01
2020-09-30$3.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03
-$25.21M
derived: sum of 2 quarters · filed 2021-11-03
-$52.23M
10-Q · filed 2021-11-03
-$82.25M
derived: sum of 4 quarters · filed 2022-02-23
2020-06-30-$28.85M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04
-$55.87M
10-Q · filed 2021-08-04
-$85.88M
derived: sum of 3 quarters · filed 2022-02-23
-$111.01M
derived: sum of 4 quarters · filed 2022-02-23
2020-03-31-$27.02M
10-Q · filed 2021-05-05
-$57.04M
derived: sum of 2 quarters · filed 2022-02-23
-$82.16M
derived: sum of 3 quarters · filed 2022-02-23
-$105.05M
derived: sum of 4 quarters · filed 2022-02-23
2019-12-31-$30.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23
-$55.14M
derived: sum of 2 quarters · filed 2022-02-23
-$78.03M
derived: sum of 3 quarters · filed 2022-02-23
-$99.57M
10-K · filed 2022-02-23
2019-09-30-$25.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04
-$48.01M
derived: sum of 2 quarters · filed 2020-11-04
-$69.56M
10-Q · filed 2020-11-04
-$90.79M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30-$22.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
-$44.43M
10-Q · filed 2020-08-05
-$65.66M
derived: sum of 3 quarters · filed 2021-02-24
-$82.47M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31-$21.55M
10-Q · filed 2020-05-06
-$42.77M
derived: sum of 2 quarters · filed 2021-02-24
-$59.58M
derived: sum of 3 quarters · filed 2021-02-24
-$77.74M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31-$21.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
-$38.04M
derived: sum of 2 quarters · filed 2021-02-24
-$56.20M
derived: sum of 3 quarters · filed 2021-02-24
-$74.31M
10-K · filed 2021-02-24
2018-09-30-$16.81M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
-$34.97M
derived: sum of 2 quarters · filed 2019-11-05
-$53.08M
10-Q · filed 2019-11-05
-$67.83M
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30-$18.16M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
-$36.27M
10-Q · filed 2019-08-07
-$36.28M
10-Q · filed 2018-08-08
-$51.02M
derived: sum of 3 quarters · filed 2020-02-26
-$64.77M
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31-$18.11M
10-Q · filed 2019-05-09
-$32.85M
derived: sum of 2 quarters · filed 2020-02-26
-$46.61M
derived: sum of 3 quarters · filed 2020-02-26
2017-12-31-$14.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
-$28.50M
derived: sum of 2 quarters · filed 2020-02-26
-$50.52M
10-K · filed 2020-02-26
2017-09-30-$13.76M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
-$35.77M
10-Q · filed 2018-11-07
2017-06-30-$22.02M
10-Q · filed 2018-08-08
2016-12-31-$25.14M
10-K · filed 2019-02-28